Targeting the equilibrative nucleoside transporter ENT1 in Huntington disease.
Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Xavier
X
Guitart
Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Yijuang
Y
Chern
Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Sergi
S
Ferré
D017668:Age of Onset; D000818:Animals; D030801:Animals, Genetically Modified; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism*; D004109:Dilazep / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D004195:Disease Models, Animal; D018450:Disease Progression; D033721:Equilibrative Nucleoside Transporter 1 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D000071058:Huntingtin Protein / Q000235:genetics; D006816:Huntington Disease / Q000378:metabolism*; D051379:Mice; D009474:Neurons / Q000378:metabolism; D051381:Rats; D043705:Receptor, Adenosine A2A / Q000378:metabolism; D000077486:Ticagrelor / Q000494:pharmacology
C000627179:ADORA2A protein, human; D015415:Biomarkers; D002352:Carrier Proteins; D033721:Equilibrative Nucleoside Transporter 1; C499524:Htt protein, rat; D000071058:Huntingtin Protein; D043705:Receptor, Adenosine A2A; C438649:SLC29A1 protein, human; C438652:Slc29a1 protein, rat; D004176:Dipyridamole; D004109:Dilazep; D000077486:Ticagrelor
ENT1; Huntington disease; Neuroscience; adenosine; adenosine A2A receptor